It doesn't mean it's not happening, and it could potentially be that starting now I do get the advantage, uh, in there.

You should start now, Matteo, because if you look at this, this is, this is not just about weight loss.

What GLP-1 does...

And you must remember now that GLP-1 is just at the beginning of a fantastic exploding trajectory.

So the G-- the first version of GLP-1s, uh, were just targeting one receptor.

Now, the, the ones that we see now, the next-- that target three receptors, and I don't see it stopping there, right? So, so what we see is this Swiss Army knife of attacking what's called the metabolic syndrome, which is not just obesity, it's diabetes, it's certain types of cancers, it's, uh, psoriasis, sleep apnea, cardiovascular diseases, what have you.

So for the healthcare sector out there, this is the magic pill that they can bring to people and radically lower their overall cost for handling all the other base, not just obesity.

Ma- uh, means, uh, knowledge, competence that, uh, we are losing over the years.